Nanobiotix (NBTX) Liabilities and Shareholders Equity (2018 - 2025)

Nanobiotix (NBTX) posted Liabilities and Shareholders Equity of $78.9 million for Q4 2025, up 9.49% on a QoQ basis from $72.0 million in Q4 2024, and up 9.49% year-over-year from $72.0 million in Q4 2024.

Nanobiotix (NBTX) has 8 years of Liabilities and Shareholders Equity data on file, last reported at $78.9 million in Q4 2025.

  • In Q4 2025, Liabilities and Shareholders Equity rose 9.49% year-over-year to $78.9 million; the TTM figure through Dec 2025 stood at $312.9 million (down 10.71% YoY), while the FY2025 annual figure was $76.6 million, up 4.92% from the prior year.
  • Liabilities and Shareholders Equity climbed to $78.9 million in Q4 2025, from $72.0 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $116.4 million in Q4 2021 and bottomed at $61.0 million in Q4 2022.
  • A 5-year average of $85.9 million and a median of $78.9 million in 2025 frame the typical range for Liabilities and Shareholders Equity.
  • Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity plunged 47.62% — and 2023, when it jumped 65.67%.
  • Year by year, Liabilities and Shareholders Equity stood at $116.4 million in 2021, then plunged by 47.62% to $61.0 million in 2022, then jumped by 65.67% to $101.0 million in 2023, then fell by 28.69% to $72.0 million in 2024, then increased by 9.49% to $78.9 million in 2025.
  • The last three Liabilities and Shareholders Equity figures came in at $78.9 million (Q4 2025), $72.0 million (Q4 2024), and $101.0 million (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 14.93 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 37.37 Mn
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 1.73 Bn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 78.88 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 33.89 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 26.48 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - 23.64 Mn
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 40.87 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 5.13 Bn
10 Revolution Medicines 32.39 Bn 32.39 Bn - 2.25 Bn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 78.88 Mn
Jun 30, 2025 51.14 Mn
Dec 31, 2024 72.04 Mn
Jun 30, 2024 93.34 Mn
Dec 31, 2023 101.03 Mn
Jun 30, 2023 44.00 Mn
Dec 31, 2022 60.98 Mn
Jun 30, 2022 86.03 Mn
Dec 31, 2021 116.42 Mn
Jun 30, 2021 149.23 Mn
Dec 31, 2020 159.80 Mn
Dec 31, 2019 62.21 Mn
Dec 31, 2018 52.73 Mn